Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma [NA]
A prospective clinico-biological database study for patients with ovarian cancer, fallopian tube cancer, or peritoneal cancer is currently r…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
This Clinical Trial update describes a study evaluating salivary RNA profiles in patients with adnexal masses of ovarian origin, including o…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: PITCH - Impacting Hereditary Cancer Testing [NA]
Clinical trial update for the PITCH study examining hereditary cancer testing and genetic counseling in ovarian cancer; the trial status is …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study [NA]
This completed clinical trial investigates lifestyle and empowerment techniques in survivorship for gynecologic cancers. The study includes …
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial results evaluating metformin in combination with chemotherapy for patients with stage III–IV ovarian, fallopian tube,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Population Based Germline Testing for Early Detection and Prevention of Cancer [NA]
Ongoing study evaluating population-based germline genetic testing for early cancer detection and prevention in individuals at risk for brea…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 studies of the radiopharmaceutical 177Lu-BetaBart. The trial is evaluating its use in…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer [Phase 1]
Phase 1 clinical trial update on the safety and immunogenicity of Innocell Autologous Cellular Immunotherapy for recurrent epithelial ovaria…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center is conducting a trial examining how estrogen, diet, and genetics relate to endometrial cancer; the st…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection [Phase 2]
Phase 2 trial assessing the imaging tracer 18F-FAPI-74 for cancer detection across multiple indications; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating HWK-007, a PTK7-directed antibody-drug conjugate, for advanced solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer [NA]
This clinical trial update describes a study comparing two surgical procedures in BRCA1 mutation carriers to assess whether the procedures r…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 clinical trial update for GB-5267 in platinum-resistant ovarian, peritoneal, or fallopian tube cancer; the study is not yet recruiti…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 study evaluating an [18F]FPyQCP PET imaging agent targeting fibroblast activation protein across colorectal cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Avera Cancer Sequencing and Analytics Protocol (ASAP)
This entry outlines the ASAP cancer sequencing and analytics protocol from Avera Cancer, currently recruiting to study sequencing-based canc…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of raludotatug deruxtecan in recurrent ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1) [NA]
A single-arm, prospective clinical trial evaluating the efficacy and safety of Daphnetin capsules combined with the TC chemotherapy regimen …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy [NA]
Recruiting trial evaluating hormone replacement therapy after risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study [NA]
This clinical trial update states that CapsuleX combined with cisplatin for platinum-resistant recurrent ovarian cancer is currently recruit…
-
EMA approval · 2026-03-25EMA Authorised: Trabectedin Accord (trabectedin) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Accord Healthcare's trabectedin (Trabectedin Accord) for use in sarcoma and ovarian cancer.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression [Phase 2]
Phase 2 study evaluating ocular toxicity risk and mitigation strategies for mirvetuximab soravtansine in patients with recurrent FR-α–positi…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours [Phase 1]
A Phase 1 trial evaluating intratumoral IVX037 in patients with advanced or metastatic solid tumours; the study is currently recruiting, foc…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 study is investigating Benmelstobart in combination with Anlotinib and oral metronomic cyclophosphamide for recurrent epithelial o…